SAN

82.76

-0.81%↓

MRK1

109.8

+0.23%↑

SHL.DE

46.12

+0.28%↑

ARGX

481

-1.13%↓

FRE

41.43

-1.12%↓

SAN

82.76

-0.81%↓

MRK1

109.8

+0.23%↑

SHL.DE

46.12

+0.28%↑

ARGX

481

-1.13%↓

FRE

41.43

-1.12%↓

SAN

82.76

-0.81%↓

MRK1

109.8

+0.23%↑

SHL.DE

46.12

+0.28%↑

ARGX

481

-1.13%↓

FRE

41.43

-1.12%↓

SAN

82.76

-0.81%↓

MRK1

109.8

+0.23%↑

SHL.DE

46.12

+0.28%↑

ARGX

481

-1.13%↓

FRE

41.43

-1.12%↓

SAN

82.76

-0.81%↓

MRK1

109.8

+0.23%↑

SHL.DE

46.12

+0.28%↑

ARGX

481

-1.13%↓

FRE

41.43

-1.12%↓

Search

Orion Oyj (Class B)

Închisă

65.95 -0.45

Rezumat

Modificarea prețului

24h

Curent

Minim

65.9

Maxim

66.95

Indicatori cheie

By Trading Economics

Venit

-12M

61M

Vânzări

-80M

355M

P/E

Medie Sector

25.565

39.564

EPS

0.44

Randament dividend

2.57

Marjă de profit

17.287

Angajați

3,943

EBITDA

202M

Dividende

By Dow Jones

Randament dividend

Medie Sector

2.57%

2.40%

Statistici piață

By TradingEconomics

Capitalizare de piață

3.4B

8.9B

Deschiderea anterioară

66.4

Închiderea anterioară

65.95

Orion Oyj (Class B) Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

14 iul. 2025, 22:07 UTC

Principalele dinamici ale pieței

Trade Desk Rises on S&P 500 Inclusion

14 iul. 2025, 17:06 UTC

Principalele dinamici ale pieței

Crypto Assets Rally Ahead of Possible U.S. Legislation

14 iul. 2025, 16:47 UTC

Achiziții, Fuziuni, Preluări

NatWest to Sell Stake in Permanent TSB

14 iul. 2025, 23:46 UTC

Market Talk

Nikkei May Rise as Yen Weakens -- Market Talk

14 iul. 2025, 23:38 UTC

Market Talk

Gold Edges Higher Ahead of U.S. CPI Data -- Market Talk

14 iul. 2025, 23:37 UTC

Market Talk

ANZ's Institutional Earnings Likely to Weigh on Outlook -- Market Talk

14 iul. 2025, 23:29 UTC

Market Talk

South32 Bull Eyes Possible Last-Minute Power Deal for Mozal -- Market Talk

14 iul. 2025, 23:29 UTC

Market Talk

Global Energy Roundup: Market Talk

14 iul. 2025, 23:02 UTC

Câștiguri

China Vanke: Additional Provision for Asset Impairment Also Among Factors Weighing on Results >000002.SZ

14 iul. 2025, 23:02 UTC

Câștiguri

China Vanke: Weakness in Overall China Real-Estate Sector Weighed on Results >000002.SZ

14 iul. 2025, 23:02 UTC

Câștiguri

China Vanke 1H Loss Was CNY9.85B >000002.SZ

14 iul. 2025, 23:01 UTC

Câștiguri

China Vanke Sees 1H Loss CNY10.0B-Loss CNY12.0B >000002.SZ

14 iul. 2025, 23:01 UTC

Câștiguri

China Vanke Expects 1H Loss to Widen >000002.SZ

14 iul. 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

14 iul. 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

14 iul. 2025, 20:07 UTC

Market Talk

Cloud Computing Giants Will Be the Winner from Software's Loss -- Market Talk

14 iul. 2025, 20:05 UTC

Market Talk

Adobe and Salesforce May Struggle to Keep Up With AI Agents -- Market Talk

14 iul. 2025, 19:11 UTC

Market Talk

Oil Retreats Despite Trump Threats of Russia Sanctions -- Market Talk

14 iul. 2025, 19:09 UTC

Market Talk

Gold Breaks a 3-Day Win Streak -- Market Talk

14 iul. 2025, 18:59 UTC

Market Talk

Hotter Weather Outlook, LNG Flows Boost U.S. Natural Gas -- Market Talk

14 iul. 2025, 18:30 UTC

Achiziții, Fuziuni, Preluări

Synopsys Buy of Ansys Gets China OK. The $35 Billion Deal Is Set to Close. -- Barrons.com

14 iul. 2025, 18:25 UTC

Market Talk

Dollar Gains, Treasury Yields Lose Steam as Trump Threatens Russia -- Market Talk

14 iul. 2025, 18:25 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

14 iul. 2025, 16:59 UTC

Market Talk

Goldman Sachs Lifts 2H25 Crude Price Views -- Market Talk

14 iul. 2025, 16:53 UTC

Acțiuni populare

Stocks to Watch Monday: Kenvue, Tesla, Synopsys, Robinhood -- WSJ

14 iul. 2025, 16:27 UTC

Market Talk

Oil Falls as Investors Monitor U.S.-EU Trade, Trump's Russia Sanction Threats -- Market Talk

14 iul. 2025, 16:20 UTC

Market Talk
Câștiguri

Auto & Transport Roundup: Market Talk

14 iul. 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

14 iul. 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

14 iul. 2025, 16:12 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Waters Closer to Thermo Fisher, Danaher With Becton Dickinson Unit -- Market Talk

Comparație

Modificare preț

Orion Oyj (Class B) Așteptări

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Orion Oyj (Class B)

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, Dexdor, and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, Entacapone, and Comtess/Comtan for Parkinson's disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer. It also offers Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler, and Buventol Easyhaler drugs for the treatment of asthma and chronic obstructive pulmonary disease. In addition, the company provides veterinary drugs comprising Bonqat, Clevor, Domosedan, Domitor, Antisedan, Dexdomitor, Domosedan Gel, Sileo, and Tessie; APIs for generic compounds and proprietary products, as well as contract manufacturing services; and markets and sells veterinary drugs manufactured by other international companies. It has partnership with Propeller Health to connect the Easyhaler(R) product portfolio; collaboration and option to license agreement with Abilita Therapeutics to develop innovative antibody therapeutics; and a research collaboration and license agreement with Amneal Pharmaceuticals, Inc. to commercialize Amneal's generic products. Orion Oyj was founded in 1917 and is headquartered in Espoo, Finland.